T. Van Cann

Lab of Exp. Oncology, KU Leuven and Department of General Medical
Oncology, UZ Leuven, LEUVEN, Belgium.

Articles

P.04 Osteonecrosis of the Jaw Incidence in Patients Treated Sequentially with Bisphosphonates and Denosumab

BJMO - 2017, issue 3, february 2017

T. Loyson , T. Van Cann , C. Politis , B. Beuselinck MD, PhD

Read more

P.05 Incidence of osteonecrosis of the jaw in patients both treated with bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

BJMO - 2017, issue 3, february 2017

T. Van Cann , T. Loyson , C. Politis , P. Debruyne MD, PhD, B. Beuselinck MD, PhD

Read more

P.10 Systemic treatment preferences for patients with advanced desmoid-type fibromatosis (DF) in Europe

BJMO - 2017, issue 3, february 2017

T. Van Cann , A. Requilé MD, P. Schöffski MD

Read more

X